254 NTX-1088, a potent anti-PVR Mab induces DNAM1-mediated antitumor immunity

• Stipan Jonjic,
• Ofer Mandelboim,
• Anas Atieh,
• Akram Obiedat,
• Guy Cinamon,
• Tihana Lenac Rovis,
• Paola Kucan Brlic,
• Lea Hirsl,
• Keren Paz,
• Pini Tsukerman

Affiliations

Stipan Jonjic

2 Department of Histology and Embryology, Faculty of Medicine, University of Rijeka, Rijeka, Croatia

Ofer Mandelboim

Immunology & Cancer Research Center, Hebrew University of Jerusalem, Jerusalem, Israel

Anas Atieh

1Nectin Therapeutics, Jerusalem, Israel

Akram Obiedat

1Nectin Therapeutics, Jerusalem, Israel

Guy Cinamon

1Nectin Therapeutics, Jerusalem, Israel

Tihana Lenac Rovis

2University of Rijeka, Rijeka, Croatia

Paola Kucan Brlic

2University of Rijeka, Rijeka, Croatia

Lea Hirsl

2University of Rijeka, Rijeka, Croatia

Keren Paz

1Nectin Therapeutics, Jerusalem, Israel

Pini Tsukerman

1Nectin Therapeutics, Jerusalem, Israel